Cystic Fibrosis Therapy Developer Novoclem Names Five Inaugural Members of Its Scientific Advisory Board
cystic fibrosis, News
Novoclem Therapeutics, which is developing nitric oxide-releasing compounds that fight infections in cystic fibrosis and other respiratory diseases, has named five inaugural members of its scientific advisory board. They are Dr. Donald VanDevanter, ... Read more